Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Dansk
English
Søg efter indhold i Region Hovedstadens forskningsportal
Forside
Hospitaler/Afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Niels Obel
Professor
,
Rigshospitalet
,
Afdeling for Infektionssygdomme HJE
1998 …
2026
Publikationer pr. år
Vis
Fingeraftryk
Netværk
Publikationer
(285)
Lignende profiler
(12)
Vejledt arbejde
(1)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Niels Obel er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Keyphrases
95% Confidence Interval
39%
AIDS/HIV
30%
Antiretroviral Therapy
35%
Antiviral Drugs
8%
Background Population
16%
Cancer Risk
9%
CD4 Cell Count
14%
CD4 Count
12%
Combined Antiretroviral Therapy (cART)
17%
Comorbidity
6%
Comparison Cohort
15%
Confidence Interval
9%
Denmark
43%
Europe
13%
Granulomatosis with Polyangiitis
7%
Hazard Ratio
10%
Hepatitis C Virus
8%
Hepatitis C Virus Infection
7%
Highly Active Antiretroviral Therapy (HAART)
32%
HIV Cohort
12%
HIV Diagnosis
11%
HIV Infection
18%
HIV Patients
17%
HIV RNA
6%
HIV-infected Patients
69%
Human Immunodeficiency Virus Type 1 (HIV-1)
28%
Incidence Rate
27%
Increased Mortality
7%
Infected Individual
11%
Infected Population
6%
Injection Drug Use
9%
Late Presentation
6%
Long-term Mortality
14%
Lyme Neuroborreliosis
7%
Matched Cohort Study
14%
Mortality Rate
15%
Mycobacterium Tuberculosis (M. tb)
6%
Myocardial Infarction
8%
National Cohort Study
88%
People Living with HIV (PLHIV)
22%
People Living with Human Immunodeficiency Virus
6%
Population Control
8%
Population-based
10%
Population-based Cohort Study
15%
Protease Inhibitors
7%
Risk Factors
11%
Risk of Death
7%
Viral Load
6%
Virological Failure
11%
Women Living with HIV (WLHIV)
7%
Medicine and Dentistry
Acquired Immune Deficiency Syndrome
5%
Antiretroviral Therapy
21%
Brain Abscess
5%
Cohort Analysis
85%
Diseases
10%
Granulomatosis with Polyangiitis
5%
Hazard Ratio
10%
Highly Active Antiretroviral Therapy
8%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
12%
Infection
11%
Lyme Neuroborreliosis
7%
Malignant Neoplasm
9%
Mortality Rate
11%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
